Payment overview · 2025
General Payments
$797.06
5 reported records · 2 companies
Healthcare provider profile · identity verified
Ali Parsaeian, MD
Allopathic & Osteopathic Physicians|Family Medicine · HUNTINGTON PARK, CA · NPI 1528229374
Verified facts
What the public records show
CMS Open Payments records show Ali Parsaeian, MD received $797.06 in general payments during 2025 across 5 reported records.
Stryker Corporation accounted for 97.7% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Stryker Corporation | Unresolved — no canonical attribution shown | $778.80 | 97.7% | 4 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $18.26 | 2.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Travel and Lodging | $513.04 | 1 |
| Food and Beverage | $284.02 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| INSPACE Normalized: inspace |
Device | Stryker Corporation | $729.00 | 3 | 2025 |
Source payment records
|
|||||
| SALVATION Normalized: salvation |
Device | Stryker Corporation | $49.80 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $18.26 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 278 | 54 |
| Amlodipine Besylate | Amlodipine Besylate | 158 | 34 |
| Metoprolol Succinate | Metoprolol Succinate | 158 | 29 |
| Gabapentin | Gabapentin | 153 | 31 |
| Levothyroxine Sodium | Levothyroxine Sodium | 149 | 23 |
| Lisinopril | Lisinopril | 130 | 23 |
| Furosemide | Furosemide | 127 | 39 |
| Pantoprazole Sodium | Pantoprazole Sodium | 113 | 24 |
| Tamsulosin Hcl | Tamsulosin Hcl | 105 | 20 |
| Alendronate Sodium | Alendronate Sodium | 95 | 14 |
| Olanzapine | Olanzapine | 94 | 14 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 85 | 28 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 82 | 28 |
| Duloxetine Hcl | Duloxetine Hcl | 82 | 15 |
| Potassium Chloride | Potassium Chloride | 80 | 20 |
| Trazodone Hcl | Trazodone Hcl | 78 | 18 |
| Mirtazapine | Mirtazapine | 76 | 14 |
| Eliquis | Apixaban | 75 | 17 |
| Hydrochlorothiazide | Hydrochlorothiazide | 74 | 13 |
| Losartan Potassium | Losartan Potassium | 74 | 15 |
| Metformin Hcl | Metformin Hcl | 74 | 16 |
| Simvastatin | Simvastatin | 74 | 11 |
| Omeprazole | Omeprazole | 73 | 17 |
| Latanoprost | Latanoprost | 69 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 69 | 15 |
| Baclofen | Baclofen | 63 | 13 |
| Famotidine | Famotidine | 60 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 57 | 11 |
| Spironolactone | Spironolactone | 55 | 11 |
| Lorazepam | Lorazepam | 54 | 17 |
| Lamotrigine | Lamotrigine | 49 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 49 | suppressed |
| Carvedilol | Carvedilol | 48 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 48 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 46 | 13 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 46 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 45 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 43 | suppressed |
| Levetiracetam | Levetiracetam | 43 | suppressed |
| Allopurinol | Allopurinol | 42 | suppressed |
| Risperidone | Risperidone | 42 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 42 | suppressed |
| Bumetanide | Bumetanide | 41 | 13 |
| Finasteride | Finasteride | 40 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 39 | suppressed |
| Aripiprazole | Aripiprazole | 37 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 37 | suppressed |
| Clonazepam | Clonazepam | 36 | suppressed |
| Lactulose | Lactulose | 36 | suppressed |
| Pregabalin | Pregabalin | 36 | suppressed |
| Bupropion Xl | Bupropion Hcl | 35 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 35 | suppressed |
| Jardiance | Empagliflozin | 33 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 33 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 32 | suppressed |
| Metoprolol Tartrate | Metoprolol Tartrate | 31 | suppressed |
| Azithromycin | Azithromycin | 30 | 14 |
| Oxycontin | Oxycodone Hcl | 30 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 29 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 29 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 29 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 28 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 28 | suppressed |
| Liraglutide | Liraglutide | 28 | suppressed |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 28 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 28 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 27 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 26 | suppressed |
| Carbamazepine Er | Carbamazepine | 26 | suppressed |
| Mirabegron Er | Mirabegron | 26 | suppressed |
| Prednisone | Prednisone | 26 | 17 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 25 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 25 | suppressed |
| Primidone | Primidone | 25 | suppressed |
| Anastrozole | Anastrozole | 24 | suppressed |
| Cephalexin | Cephalexin | 24 | 13 |
| Memantine Hcl | Memantine Hcl | 24 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 23 | suppressed |
| Clozapine | Clozapine | 23 | suppressed |
| Ezetimibe | Ezetimibe | 23 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 23 | 11 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 23 | suppressed |
| Topiramate | Topiramate | 23 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 21 | suppressed |
| Valsartan | Valsartan | 21 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 20 | suppressed |
| Ibuprofen | Ibuprofen | 20 | 14 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 20 | 14 |
| Amitriptyline Hcl | Amitriptyline Hcl | 19 | suppressed |
| Fentanyl | Fentanyl | 19 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 19 | suppressed |
| Lumigan | Bimatoprost | 19 | suppressed |
| Qvar Redihaler | Beclomethasone Dipropionate | 19 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 19 | 13 |
| Glimepiride | Glimepiride | 18 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 17 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 17 | suppressed |
| Lithium Carbonate Er | Lithium Carbonate | 17 | suppressed |
| Torsemide | Torsemide | 17 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 16 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 16 | suppressed |
| Ozempic | Semaglutide | 16 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 16 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 15 | suppressed |
| Atenolol | Atenolol | 15 | suppressed |
| Atrovent Hfa | Ipratropium Bromide | 15 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 15 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 15 | suppressed |
| Entresto | Sacubitril/Valsartan | 15 | suppressed |
| Glipizide | Glipizide | 15 | suppressed |
| Pregabalin Er | Pregabalin | 15 | suppressed |
| Sucralfate | Sucralfate | 15 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 14 | 12 |
| Clonidine Hcl | Clonidine Hcl | 14 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 14 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 14 | suppressed |
| Meloxicam | Meloxicam | 14 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 14 | suppressed |
| Cevimeline Hcl | Cevimeline Hcl | 13 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 13 | suppressed |
| Ondansetron Odt | Ondansetron | 13 | suppressed |
| Prasugrel Hcl | Prasugrel Hcl | 13 | suppressed |
| Tradjenta | Linagliptin | 13 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 13 | suppressed |
| Alprazolam | Alprazolam | 12 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 12 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 12 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 12 | suppressed |
| Glatopa | Glatiramer Acetate | 12 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 12 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 12 | suppressed |
| Naltrexone Hcl | Naltrexone Hcl | 12 | suppressed |
| Nitroglycerin | Nitroglycerin | 12 | 12 |
| Oxycodone Hcl | Oxycodone Hcl | 12 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 12 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 12 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 12 | suppressed |
| Tymlos | Abaloparatide | 12 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 11 | suppressed |
| Budesonide Ec | Budesonide | 11 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 11 | suppressed |
| Glyburide | Glyburide | 11 | suppressed |
| Myrbetriq | Mirabegron | 11 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 11 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 11 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 11 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $797.06 · 5 records | Stryker Corporation | Cologuard Collection Kit, INSPACE, SALVATION | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error